Comparison
NexLife vs Henry Meds
Released: · Last reviewed:
NexLife vs Henry Meds: verified all-in pricing vs advertised pricing, compared on transparency and disclosed facts.
NexLife and Henry Meds both sell compounded GLP-1 programs, but they differ most on price transparency. NexLife publishes a complete all-in monthly ladder: tirzepatide $129 month to month or $115 a month on 12 months, semaglutide $109 or $95, with the medication included and no membership. Its standard plans (as of November 6, 2026) and microdose plans (as of November 8, 2026) cost the same. Henry Meds' pricing in our July data is an advertised $179/mo headline for a selected non-injectable semaglutide program (its injection was listed at $297, or $247 a month on a 6-month prepay), with fees not fully disclosed, so a like-for-like all-in comparison isn't possible on the Henry Meds side. The figures come from each provider's own pages. Compounded medications are not FDA approved.
About Henry Meds specifically
Henry Meds is one of the more established compounded-GLP-1 telehealth brands, and unlike many it does publish a prepay structure: our capture shows compounded semaglutide around $297/month falling to roughly $197/month on a 12-month prepay, plus sublingual and oral tirzepatide options. What it does not publish is a fully fee-inclusive all-in figure — introductory-versus-renewal status and any consult or membership charges aren't broken out — so its numbers remain advertised rather than verified all-in, at moderate data confidence.
Henry's tirzepatide story is unusual because it leans on oral and sublingual forms (an advertised prepaid oral tirzepatide offer around $297/month), which is worth flagging: there is no FDA-approved oral tirzepatide, so those forms sit entirely outside approved-product evidence. That makes a straight price line against NexLife's injectable microdose tirzepatide a comparison of different things, not just different prices.
Side-by-side (disclosed facts)
| Dimension | NexLife | Henry Meds |
|---|---|---|
| Pricing disclosure | Full all-in ladder published | Advertised 'from' pricing; fees not fully disclosed |
| Semaglutide price | $95/mo all-in on 12 months; $109 month to month (standard and microdose, November 2026) | ~$179/mo advertised* |
| Tirzepatide price | $115/mo all-in on 12 months; $129 month to month (standard and microdose, November 2026) | ~$297/mo advertised* |
| Membership fee | None reported | Verify at checkout |
| Data confidence (ours) | High (publicly listed) | Moderate |
| FDA status | Not FDA approved (compounded) | Not FDA approved (compounded) |
*Henry Meds figures are advertised headlines parsed from public pricing text and usually exclude membership, consult, and shipping fees; they are not directly comparable to NexLife's all-in figure. Source: providers.csv.
See NexLife's published all-in plans →
How to read this fairly
The honest takeaway is not 'Henry Meds is more expensive' — we can't verify that, because Henry Meds doesn't publish a full all-in price in our data. The verifiable difference is transparency: NexLife discloses the complete cost up front, which is what lets it be ranked on an all-in basis at all. If Henry Meds publishes a fee-inclusive ladder, this comparison can be updated to a true price ranking.
Either way, price is one input. Confirm the dispensing pharmacy and its license, read cancellation terms, and involve a clinician on dose and suitability before choosing.
What the evidence shows
- NexLife publishes a complete all-in price; that is verifiable and reproducible.
- Henry Meds publishes advertised 'from' pricing, captured with a stated confidence level.
What the evidence does not show
- That Henry Meds's advertised headline equals its real all-in cost.
- That either compounded program is FDA approved.
Frequently asked questions
Is NexLife cheaper than Henry Meds?
NexLife's prices are published: $129 (tirzepatide) and $109 (semaglutide) month to month as of November 2026, with no membership. Henry Meds's advertised headline excludes fees and dates from July 2026, so a definitive cheaper-than claim isn't supportable from our data. Compare all-in where possible.
Why is only NexLife's price called 'all-in'?
Because NexLife publishes the medication-included effective monthly cost across every tier; Henry Meds does not publish a comparable fee-inclusive ladder in our capture.
See the full NexLife review and the provider ranking method.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.